Drugdiscovery >> Clinical Trials >> News
4904
Views
title
Theravance’s experimental COPD drug meets study goal - drugdiscovery.com


Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial.
Read More >>


Tags: Theravance, experimental drug, COPD, lung disease, clinical trial - September 7, 2013
Related Articles
21001
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

6296
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

5995
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

5276
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

3588
Views
Experimental durg of  Pfizer gives promising results in prevention of community acquired pneumonia Experimental durg of Pfizer gives promising results in prevention of community acquired pneumonia
Pfizer has just finished its landmark stuy over a pnemonia drug. The trial which is based on over 85,000 samples and the new treatment seems to be very effective on patient 65 years and over. Read More >>

Tags: drug; discovery, development, news, Pfizer, CAPITA, clinical trial, CAP, pneumonia, primary endpoint

2994
Views
BMS diabetes drug successful in late-stage study BMS diabetes drug successful in late-stage study
Bristol-Myers Squibb has announced that its diabetes drug dapagliflozin, helped improve blood sugar levels and reduce body weight in patients with type 2 diabetes who were taking a combination of metf Read More >>

Tags: type 2 diabetes, Bristol-Myers Squibb, dapagliflozin, clinical trial, Forxiga

3764
Views
Somatuline successful in the ELECT study Somatuline successful in the ELECT study
Ipsen ELECT study met its primary endpoint, which aimed to assess the effect of Somatuline Injection on the control of symptoms in patients with neuroendocrine tumors (NETs) associated with carcinoid Read More >>

Tags: somatuline, neuroendocrine tumors, carcinoid syndrome

7208
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

3249
Views
Auris medical's first patient entered in Phase III Study for tinnitus Auris medical's first patient entered in Phase III Study for tinnitus
Auris announced that the first patient has entered the clinical trial phase III in Europe. Read More >>

Tags: europe, PhasII, Auris, Tinnitus

5108
Views
Tresiba efficient in type 2 diabetes patients - study shows Tresiba efficient in type 2 diabetes patients - study shows
The results of the study demonstrate that Novo Nordisk’s recently launched drug Tresiba (insulin degludec) enables patients with type 2 diabetes to sustain good long-term glycemic control, when used Read More >>

Tags: Tresiba, glycemic control, type 2 diabetes, Novo Nordisk, insulin degludec

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013